Nyhet
Denator signs agreement with partner in Switzerland
2010-02-23 15:27
The Göteborg-based company has signed a distribution agreement with a Swiss company to handle service and sales in the country.
The distribution agreement with Swiss partner Bucher Biotech relates to Denator´s Stabilizor T1 technology for inactivating enzymes with the help of heat. This technology is used to stabilise tissue samples and to inactivate enzymes that break down other sample components. The agreement encompasses service and sales in Switzerland.
“This helps us build up global interest in Denator´s products and ensures that we can give our protein analysis scientists support at the local level," says company CEO Olof Sköld.
Picture: Biotech Sweden
Contact person: Olof Sköld, olof.skold@denator.se
Kategorisering
- Regioner:
- Göteborg
- Tags:
- denator,
- life sciences,
- life science,
- health care,
- göteborg,
- göteborgbio,
- biomedicine,
- biomedicin,
- stabilizor t1 technology for inactivating enzymes,
- protein analysis,
- www.denator.se,
- www.goteborgbio.se,
- olof sköld
Lägg till kommentarKommentaren sparades
Innan den publiceras måste den godkännas av GöteborgBIO.